1. Home
  2. BLNK vs NAUT Comparison

BLNK vs NAUT Comparison

Compare BLNK & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blink Charging Co.

BLNK

Blink Charging Co.

N/A

Current Price

$0.58

Market Cap

94.6M

ML Signal

N/A

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

N/A

Current Price

$3.89

Market Cap

383.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BLNK
NAUT
Founded
2009
2016
Country
United States
United States
Employees
N/A
130
Industry
Industrial Specialties
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
94.6M
383.5M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
BLNK
NAUT
Price
$0.58
$3.89
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$1.95
$4.00
AVG Volume (30 Days)
1.5M
284.9K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
38.94
16.07
EPS
N/A
N/A
Revenue
$126,197,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.87
$992.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.62
52 Week High
$2.65
$3.98

Technical Indicators

Market Signals
Indicator
BLNK
NAUT
Relative Strength Index (RSI) 35.77 79.96
Support Level N/A $1.82
Resistance Level $0.72 N/A
Average True Range (ATR) 0.03 0.30
MACD -0.00 0.13
Stochastic Oscillator 25.13 98.06

Price Performance

Historical Comparison
BLNK
NAUT

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: